CD274 and non-small cell lung carcinoma: In order to identify potential sources of heterogeneity, subgroup analyses were performed based on PD-L1 expression, TMB, medication combinations, non-small cell lung cancer stage, median age, gender, histology and smoking status (Table 2, Table 3).